Investing in risky growth stocks can sometimes lead to significant payoffs. Celsius, Mara, and Super Micro Computer have produced 10x returns in just five years. These companies still face some risks, ...
Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...
The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease ...
Novo Nordisk A/S’s blockbuster Ozempic won US approval to treat chronic kidney disease in patients who also have type 2 ...
4d
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...
The good news is that the risk for thyroid cancer linked to GLP-1 drugs appears low, but higher detections in the first year, ...
Colorado plans to limit insurance coverage for weight-loss drugs like Wegovy and Ozempic for thousands of state employees.
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...
started paying for GLP-1s for weight loss in 2015. By 2023, 23,215 beneficiaries were on the drugs, up from 2,795 in 2021 — an increase of 731%. With various discounts and rebates, the health plan was ...
About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...
A new study from the Department of Veteran Affairs, published in Nature Medicine, found that GLP-1 weight loss drugs including Mounjaro, Ozempic, Wegovy and Zepbound, may offer benefits beyond weight ...
A ticket purchased in Michigan matched 5 numbers for a $1 million prize. Mega Millions tickets start at $2 apiece. Below are some frequently asked questions about the game, when winning tickets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback